Variant gamma-glutamyltransferases in colorectal carcinomas

Area of Science:

• Biochemistry
• Oncology
• Glycobiology

Background:

• Gamma-glutamyltransferase (GGT) is an enzyme implicated in various physiological and pathological processes.
• Altered glycosylation patterns of proteins are a hallmark of cancer, affecting protein function and stability.
• Understanding GGT heterogeneity in colorectal cancer can provide insights into tumor biology.

Purpose of the Study:

• To identify and characterize novel variants of gamma-glutamyltransferase (GGT) in colorectal carcinomas.
• To compare the biochemical properties of GGT variants in cancer with the enzyme in normal colonic mucosa.
• To investigate potential differences in post-translational modifications, specifically concerning the carbohydrate moiety.

Main Methods:

• Enzyme purification and characterization from colorectal carcinoma tissues and normal colonic mucosa.
• Affinity chromatography using concanavalin A to assess differences in glycosylation.
• Electrophoretic techniques to analyze charge heterogeneity.
• Assessment of sialic acid content.
• Size and antigenicity analysis.

Main Results:

• Two distinct GGT variants were identified in colorectal carcinomas.
• One variant displayed reduced affinity for concanavalin A and significant charge heterogeneity, attributed to variable sialic acid content.
• The second variant was identified as an asialo form with no concanavalin A affinity.
• Both novel variants were found to be identical in size and antigenicity to the normal GGT enzyme.

Conclusions:

• Colorectal carcinomas express unique gamma-glutamyltransferase variants.
• These variants likely arise from distinct post-translational modifications of the enzyme's carbohydrate structures.
• The observed heterogeneity in GGT glycosylation may have implications for colorectal cancer diagnosis or prognosis.